Skip to main content
Fachgebiete
Automobil + Motoren Bauwesen + Immobilien Business IT + Informatik Elektrotechnik + Elektronik Energie + Nachhaltigkeit Finance + Banking Management + Führung Marketing + Vertrieb Maschinenbau + Werkstoffe Versicherung + Risiko
DE
EN
Themenseiten
Organisationspsychologie Projektmanagement Marketing Smart Manufacturing
Bücher
Zeitschriften
Weitere Formate
Podcasts Webinare Technik Webinare Wirtschaft Kongresse Veranstaltungskalender Awards
Jetzt Einzelzugang starten
Zugang für Unternehmen
Referenzkunden
MTZ-Fachkongress

Antriebe und Energiesysteme von morgen


Austausch von Automobil- und Energiewirtschaft

Am 14./15. Mai geht es in Chemnitz um die Mobilitätswende durch Elektro- und Wasserstofffahrzeuge.
Erweiterte Suche
Anmelden
nach oben
Erschienen in:
The Dynamic Context and Multiple Challenges of Data Sharing Kapitel lesen Erstes Kapitel lesen

2024 | OriginalPaper | Buchkapitel

Consent and Retrospective Data Collection

verfasst von : Tima Otu Anwana, Katarzyna Barud, Michael Cepic, Emily Johnson, Max Königseder, Marie-Catherine Wagner

Erschienen in: The Law and Ethics of Data Sharing in Health Sciences

Verlag: Springer Nature Singapore

Einloggen

Aktivieren Sie unsere intelligente Suche, um passende Fachinhalte oder Patente zu finden.

search-config
loading …

Abstract

The secondary use of health data offers great potential for health research. Technological developments, for instance the progress in the field of artificial intelligence, have improved the reusability of datasets. However, the GDPR and ethical guidelines regularly restrict the reuse of personal data when the data subject has not given their informed or explicit consent. In retrospective studies, where researchers use personal data and sensitive data from previous medical examinations, the retrospective collection of the patient's consent can be challenging. This chapter will focus on the potential legal and practical hurdles associated with obtaining consent from the data subject for a new processing purpose. In addition, it will present the ethical considerations associated with consent and retrospective data collection in health and medical research. This chapter will discuss several Horizon 2020 funded research projects in the areas of health and medical research. These research projects will be used as practical examples to demonstrate the issues faced with consent as a legal basis in retrospective research.

Sie haben noch keine Lizenz? Dann Informieren Sie sich jetzt über unsere Produkte:

Springer Professional "Wirtschaft+Technik"

Online-Abonnement

Mit Springer Professional "Wirtschaft+Technik" erhalten Sie Zugriff auf:

  • über 102.000 Bücher
  • über 537 Zeitschriften

aus folgenden Fachgebieten:

  • Automobil + Motoren
  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Elektrotechnik + Elektronik
  • Energie + Nachhaltigkeit
  • Finance + Banking
  • Management + Führung
  • Marketing + Vertrieb
  • Maschinenbau + Werkstoffe
  • Versicherung + Risiko

Jetzt Wissensvorsprung sichern!

Jetzt informieren

Springer Professional "Wirtschaft"

Online-Abonnement

Mit Springer Professional "Wirtschaft" erhalten Sie Zugriff auf:

  • über 67.000 Bücher
  • über 340 Zeitschriften

aus folgenden Fachgebieten:

  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Finance + Banking
  • Management + Führung
  • Marketing + Vertrieb
  • Versicherung + Risiko




Jetzt Wissensvorsprung sichern!

Jetzt informieren
Vorheriges Kapitel Dobbs in a Technologized World: Implications for US Data Privacy
Nächstes Kapitel Enabling Secondary Use of Health Data for the Development of Medical Devices Based on Machine Learning
Fußnoten
1
European Commission (2021b).
 
2
European Commission, Why the EU Supports Health Research and Innovation. Available at: https://​ec.​europa.​eu/​info/​research-and-innovation/​research-area/​health-research-and-innovation_​en. Accessed 27 March 2023.
 
3
European Commission (2021b).
 
4
European Data Protection Board, ‘Guidelines 05/2020 on Consent Under Regulation 2016/679’. Adopted on 4 May 2020 7.
 
5
Regulation (EU) 2016/679 of the European Parliament and of the Council of 27 April 2016 on the protection of natural persons with regard to the processing of personal data and on the free movement of such data, and repealing Directive 95/46/EC (General Data Protection Regulation).
 
6
 
7
InteropEHRate, https://​www.​interopehrate.​eu/​. Accessed 27 March 2023.
 
8
ProCAncer-I, https://​www.​procancer-i.​eu/​about/​. Accessed 27 March 2023.
 
10
KATY, https://​katy-project.​eu/​. Accessed 27 March 2023.
 
11
This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No. 821511.
 
12
This project has received funding from the European Union’s Horizon 2020 research and innovation program under grant agreement No. 826106.
 
13
This project has received funding from the European Union's Horizon 2020 research and innovation program under grant agreement No. 952159.
 
14
This project has received funding from the European Union’s Horizon 2020 research and innovation program under grant agreement No. 826421.
 
15
This project has received funding from the European Union’s Horizon 2020 research and innovation program under grant agreement No. 101017453.
 
16
Clinical Trials Regulation (EU) 536/2014.
 
17
See Talari and Goyal (2020), p. 409.
 
18
See Talari and Goyal (2020), p. 398.
 
19
Hess (2004), p. 1171.
 
20
See Talari and Goyal (2020), p. 398.
 
21
See Talari and Goyal (2020), p. 401; Euser et al. (2009), p. 215–216.
 
22
See Euser et al. (2009), p. 216.
 
23
See Talari and Goyal (2020), p. 399.
 
24
Hess (2004), p. 1172.
 
25
Talari and Goyal (2020), p. 399.
 
26
Doll and Hill (1950), pp. 739–748.
 
27
Talari and Goyal (2020), p. 401.
 
28
More information on broad consent is provided in Sect. 4.
 
29
GDPR, Article 9(2)(j).
 
30
Donelly and McDonagh (2019), p. 112.
 
31
Bundesdatenschutzgesetz (BDSG), paragraph 27(1).
 
32
Article 110-bis (1) D.Lgs 196/2003 (as modified by D.Lgs. 101/2018).
 
33
This will be described in more detail in Sect. 7.
 
34
ECJ 11.11.2020, C‑61/19 (ECLI:EU:C:2020:901, Orange România SA) 34 with further case law.
 
35
ECJ 11.11.2020, C‑61/19 (ECLI:EU:C:2020:901, Orange România SA) 38.
 
36
ECJ 1.10.2019, C-673/17 (ECLI:EU:C:2019:801, Planet49 GmbH) 74.
 
37
Article 29 Data Protection Working Party, Guidelines on consent under Regulation 2016/679, 17/EN, WP259 rev.01 (2018) 15 f.
 
38
On the fundamentals of the broad consent concept see Strech et al. (2016), pp. 295–309.
 
39
Cepic (2021).
 
40
Hallinan (2020).
 
41
European Data Protection Board, “EDPB Document on Response to the Request from the European Commission for Clarifications on the Consistent Application of the GDPR, Focusing on Health Research,” February 2, 2021, https://​edpb.​europa.​eu/​sites/​default/​files/​files/​file1/​edpb_​replyec_​questionnaireres​earch_​final.​pdf. Accessed 27 March 2023.
 
42
In this way also Donelly and McDonagh (2019).
 
43
Likewise tending to reject broad consent: Article 29 Working Party Guidelines on consent under Regulation 2016/679, 17/EN WP259 rev.01 (2017) 28.
 
44
Datenschutzkonferenz (2020).
 
45
Medizininformatik-Initiative (2020).
 
46
Hänold (2020).
 
47
Quinn (2021).
 
48
Cepic (2021).
 
49
European Commission (2021a), p. 58.
 
50
Article 29 Data Protection Working Party (2014), margin number 15.
The articles referenced in Opinion 06/2014 are arts 7 and 8 of the Data Protection Directive which are the forerunners of arts 6 and 9 respectively of the GDPR.
 
51
EDPB, Guidelines 03/2020 on the processing of data concerning health for the purpose of scientific research in the context of the COVID-19 outbreak (2020), margin number 17 and 18.
 
52
EDPB, Guidelines 05/2020 on consent under Regulation 2016/679, Version 1.1. (2020), margin number 91.
 
53
See Mester in Taeger/Gabel (2022), margin number 18; Schiff in Ehmann/Selmayr (2017), margin number 30.
 
54
GDPR, Article 7(3).
 
56
Chico (2018) p. 117.
 
57
Staunton et al. (2019), p. 1161.
 
58
GDPR, Article 9(4).
 
59
European Commission (2021a), p. 76; Austrian Federal Gene Technology Act (Gentechnikgesetz), paragraph 66.
 
60
European Commission (2021a), p. 77.
 
61
European Commission (2021a), p. 77.
 
62
Clarke et al. (2019), p. 1132.
 
63
GDPR, Article 6(1).
 
64
GDPR, Article 6(4).
 
65
GDPR, Recital 50.
 
66
GDPR, Article 6(4); Recital 50.
 
67
Article 29 Data Protection Working Party (2013), p. 3.
 
68
GDPR, Article 5(1)(b).
 
69
European Commission (2022).
 
70
Article 29 Data Protection Working Party (2013), p. 28.
 
71
Albers and Veit in Wolff/Brink (2020), Article 6, margin number 71 ff.
 
72
Horton (2002), p. 107.
 
73
World Medical Association (2022).
 
74
GDPR, Article 4(11).
 
75
Wu et al. (2019).
 
76
Declaration of Helsinki, paragraph 26.
 
77
Article 29 Data Protection Working Party (2017), p. 5.
 
78
Article 29 Data Protection Working Party (2017), p. 7.
 
79
Habiba (2000).
 
80
Chipidza et al. (2015).
 
81
Helsinki Declaration, paragraph 31.
 
82
Wendler and Wertheimer (2017).
 
83
The UK BioBank is a large-scale biomedical database and research resource, which aims to help the research community to improve public health.
 
84
UK Biobank (n.d.).
 
85
UK Biobank (2007).
 
86
InteropEHRate Project (2020).
 
Literatur
Albers and Veit in Wolff/Brink (eds) (2020) BeckOK Datenschutzrecht, Artikel 6 Rechtmäßigkeit der Verarbeitung
Article 29 Data Protection Working Party. Opinion 03/2013 on Purpose Limitation, April 2, 2013
Article 29 Data Protection Working Party. Opinion 06/2014 on the Notion of Legitimate Interests of the Data Controller under Article 7 of Directive 95/46/EC, April 19, 2014
Article 29 Data Protection Working Party. Guidelines on Consent under Regulation 2016/679, November 28, 2017
Austrian Federal Gene Technology Act (Gentechnikgesetz—GTG), paragraph 66
Cepic M (2021) Broad consent: die Erweiterte Einwilligung in Der Forschung. Beck-Online ZD-Aktuell 05214
Chico V (2018) The impact of the general data protection regulation on health research. Br Med Bull 128(1):109–118CrossRef
Chipidza FE, Wallwork RS and Stern TA (2015) Impact of the doctor-patient relationship. Primary Care Companion for CNS Disord 17(5):10.4088
Clarke N, Vale G, Reeves EP, Kirwan M, Smith D, Farrell M, Hurl G, McElvaney NG (2019) GDPR: an impediment to research? Ir J Med Sci 188(4):1129–1135CrossRef
Doll R, Hill AB (1950) Smoking and carcinoma of the lung. BMJ 2(4682):739–748CrossRef
Donnelly M, McDonagh M (2019) Health research, consent and the GDPR exemption. Eur J Health Law 26(2):97–119
EU General Data Protection Regulation (GDPR): Regulation (EU) 2016/679 of the European Parliament and of the Council of 27 April 2016 on the protection of natural persons with regard to the processing of personal data and on the free movement of such data, and repealing Directive 95/46/EC
European Commission (2021a) Assessment of the EU Member States’ Rules on Health Data in the Light of GDPR Specific Contract No SC 2019 70 02 in the Context of the Single Framework Contract Chafea/2018/Health/03. DG Health and Food Safety, February 12, 2021
European Data Protection Board. Guidelines 05/2020 on Consent under Regulation 2016/679, Version 1.1, May 4, 2020
European Data Protection Board. Guidelines 03/2020 on the Processing of Data Concerning Health for the Purpose of Scientific Research in the Context of the COVID-19 Outbreak, April 21, 2021
Euser AM, Zoccali C, Jager KJ, Dekker FW (2009) Cohort studies: prospective versus retrospective. Nephron Clin Pract 113(3):214–217CrossRef
Habiba MA (2000) Examining consent within the patient-doctor relationship. J Med Ethics 26(3):183–187CrossRef
Hallinan D (2020) Broad consent under the GDPR: an optimistic perspective on a bright future. Life Sci Soc Policy 16(1):2–18CrossRef
Hänold S (2020) DSK: Zustimmung Zu Broad-Consent-Formular Der Medizininformatik-Initiative. Beck-Online ZD-Aktuell 07198
Hess DR (2004) Retrospective studies and chart reviews. Respir Care J 49(10):1171–1174
Horton J (2002) Principles of biomedical ethics. Trans R Soc Trop Med Hyg 96(1):107CrossRef
Mester in Taeger/Gabel (eds) (2022) DSGVO/BDSG/TTDSG, Artikel 9
Musmade PB, Nijhawan LP, Udupa N, Bairy KL, Bhat KM, Janodia MD, Muddukrishna BS (2013) Informed consent: issues and challenges. J Adv Pharm Technol Res 4(3):134CrossRef
Quinn P (2021) Research under the GDPR—a level playing field for public and private sector research? Life Sci Soc Policy 17(1):3–33CrossRef
Regulation (EU) No 536/2014 of the European Parliament and of the Council of 16 April 2014 on clinical trials on medicinal products for human use, and repealing Directive 2001/20/EC
Schiff A in Ehmann/Selmayr (eds) (2017). Datenschutz-Grundverordnung: DS-GVO, Artikel 9 - Verarbeitung besonderer Kategorien personenbezogener Daten
Staunton C, Slokenberga S, Mascalzoni D (2019) The GDPR and the research exemption: considerations on the necessary safeguards for research biobanks. Eur J Hum Genet 27(8):1159–1167CrossRef
Strech D, Bein S, Brumhard M, Eisenmenger W, Glinicke C, Herbst T, Jahns R et al (2016) A template for broad consent in biobank research. Results and explanation of an evidence and consensus-based development process. Eur J Med Genet 59(6–7):295–309CrossRef
Talari K, Goyal M (2020) Retrospective studies—utility and caveats. J Royal Coll Phys Edinb 50(4):389–402
Wendler D, Wertheimer A (2017) Why is coerced consent worse than no consent and deceived consent? J Med Philos: Forum Bioeth Philos Med 42(2):114–131CrossRef
Wu Y, Howarth M, Zhou C, Hu M, Cong W (2019) Reporting of ethical approval and informed consent in clinical research published in leading nursing journals: a retrospective observational study. BMC Med Ethics 20(1):2–10CrossRef
Metadaten
Titel
Consent and Retrospective Data Collection
verfasst von
Tima Otu Anwana
Katarzyna Barud
Michael Cepic
Emily Johnson
Max Königseder
Marie-Catherine Wagner
Copyright-Jahr
2024
Verlag
Springer Nature Singapore
Buch
The Law and Ethics of Data Sharing in Health Sciences

Print ISBN: 978-981-9965-39-7

Electronic ISBN: 978-981-9965-40-3

Copyright-Jahr: 2024

DOI
https://doi.org/10.1007/978-981-99-6540-3_7